LEIDEN, – BIOKÉ, a Cell Signaling Technology Europe (CST Europe) company, and Advanced Cell Diagnostics, Inc. (ACD) announced that they have entered a distribution agreement, effective May 1st, 2012. The agreement emphasizes the commitment of BIOKÉ to develop personal and lasting relationships with strong and reliable partners to secure scientific excellence in a highly competitive research area like molecular pathology. BIOKÉ will assume a leadership position in the Benelux countries in the promotion, sales, and high level technical and customer support for ACD products.

ACD’s products and services are based on its proprietary RNAscope® technology, an in situ hybridization platform capable of detecting and quantifying RNA biomarkers at single molecule sensitivity. It offers single and multiplex readouts in chromogenic and fluorescent formats. ACD’s RNAscope® technology adds an important new dimension to BIOKÉ’s tools for next generation life science as it bridges the gap between DNA and protein in situ analyses. Pathologists and researchers now dispose of a toolset to profile single cell gene expression in situ, unlocking the full potential of RNA biomarkers and their further translation to clinical diagnostics.

For information about how to order products from ACD in the BeNeLux, please contact BIOKÉ at tel.: +31 (0)71 568 1000, or email: info@bioke.com

About Advanced Cell Diagnostics, Inc

Headquartered in Hayward, California, Advanced Cell Diagnostics, Inc. (ACD) has positioned as a leader in the emerging field of molecular pathology, through its innovative developments in cell- and tissue-based diagnostic tests for personalized medicine. The Company’s proprietary technology, RNAscope®, represents the first multiplex fluorescent and chromogenic in situ hybridization platform focus on the detection and quantification of RNA biomarkers in situ at single molecule level. ACD is committed in the validation of biomarkers for targeted therapeutic developments in cancer and other diseases. Responsible collaboration lines with pharmaceutical and biotechnology companies provides the foundation for ACD to develop companion diagnostic tests in conjunction with partners’ targeted therapeutics, in addition to ACD’s internal programs to develop proprietary diagnostic tests. For further information regarding ACD, please visit www.acdbio.com

About BIOKÉ

BIOKÉ, founded in 2004, is a leading provider of Life Science and Diagnostics solutions in the Benelux. The young and dynamic company provides innovative, high-performance applications for genomics, proteomics, and molecular diagnostics. With its technologies and equipment, BIOKÉ helps accelerate and improve diagnostics and research activities by enabling reproducible results. BIOKÉ is more than a technology and equipment supplier. The company provides with customized solutions, including service support – not as a contractor, but as a knowledge partner. For further information regarding BIOKÉ, please visit www.bioke.com